2020 Q3 Form 10-Q Financial Statement

#000114036120024396 Filed on November 03, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $323.6M $318.6M $317.7M
YoY Change 1.86% -1.85% -7.31%
Cost Of Revenue $218.0M $233.1M $215.3M
YoY Change 1.25% 6.68% -5.24%
Gross Profit $105.5M $85.50M $102.4M
YoY Change 3.03% -19.34% -11.42%
Gross Profit Margin 32.61% 26.84% 32.24%
Selling, General & Admin $61.60M $99.90M $63.60M
YoY Change -3.14% 64.31% -2.6%
% of Gross Profit 58.39% 116.84% 62.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.30M $13.30M $14.00M
YoY Change -12.14% -5.67% 6.87%
% of Gross Profit 11.66% 15.56% 13.67%
Operating Expenses $61.60M $100.0M $63.60M
YoY Change -3.14% 64.47% -2.6%
Operating Profit $41.16M -$14.50M $38.79M
YoY Change 6.1% -132.08% -22.89%
Interest Expense $3.497M -$4.600M $4.936M
YoY Change -29.15% -13.21% -8.71%
% of Operating Profit 8.5% 12.73%
Other Income/Expense, Net
YoY Change
Pretax Income $37.66M -$19.00M $33.85M
YoY Change 11.24% -147.62% -24.61%
Income Tax $4.700M -$2.100M $2.000M
% Of Pretax Income 12.48% 5.91%
Net Earnings $32.91M -$17.00M $31.87M
YoY Change 3.26% -151.67% -32.48%
Net Earnings / Revenue 10.17% -5.34% 10.03%
Basic Earnings Per Share
Diluted Earnings Per Share $777.8K -$401.9K $754.1K
COMMON SHARES
Basic Shares Outstanding 42.32M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.90M $21.20M $34.40M
YoY Change -21.8% -33.54% -6.52%
Cash & Equivalents $26.90M $21.15M $34.42M
Short-Term Investments
Other Short-Term Assets $102.2M $131.3M $43.20M
YoY Change 136.57% 192.43% 2.61%
Inventory $401.0M $422.5M $470.1M
Prepaid Expenses
Receivables $222.4M $213.2M $244.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $752.5M $788.2M $792.4M
YoY Change -5.04% -4.21% -5.09%
LONG-TERM ASSETS
Property, Plant & Equipment $429.5M $437.2M $489.9M
YoY Change -12.33% -10.97% -0.47%
Goodwill $407.0M
YoY Change -2.19%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $108.5M $80.94M $73.40M
YoY Change 47.82% 21.19% -5.9%
Total Long-Term Assets $961.4M $951.9M $986.2M
YoY Change -2.51% -5.0% -1.97%
TOTAL ASSETS
Total Short-Term Assets $752.5M $788.2M $792.4M
Total Long-Term Assets $961.4M $951.9M $986.2M
Total Assets $1.714B $1.740B $1.779B
YoY Change -3.64% -4.65% -3.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $93.50M $94.70M $103.6M
YoY Change -9.75% -28.15% 6.8%
Accrued Expenses $74.30M $60.10M $65.60M
YoY Change 13.26% 10.07% -11.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $20.61M $0.00
YoY Change 2.82% -100.0%
Long-Term Debt Due $24.50M $0.00 $20.20M
YoY Change 21.29%
Total Short-Term Liabilities $212.0M $201.4M $192.2M
YoY Change 10.3% -6.21% -1.03%
LONG-TERM LIABILITIES
Long-Term Debt $537.1M $598.5M $617.0M
YoY Change -12.95% -13.2% -17.29%
Other Long-Term Liabilities $53.10M $17.81M $44.60M
YoY Change 19.06% 108.24% 49.16%
Total Long-Term Liabilities $590.2M $616.3M $661.6M
YoY Change -10.79% -11.72% -14.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $212.0M $201.4M $192.2M
Total Long-Term Liabilities $590.2M $616.3M $661.6M
Total Liabilities $817.2M $817.7M $881.9M
YoY Change -7.34% -10.42% -11.34%
SHAREHOLDERS EQUITY
Retained Earnings $1.536B
YoY Change 1.31%
Common Stock $103.8M
YoY Change -3.02%
Preferred Stock
YoY Change
Treasury Stock (at cost) $595.3M
YoY Change -0.41%
Treasury Stock Shares $11.68M
Shareholders Equity $896.8M $881.6M $896.7M
YoY Change
Total Liabilities & Shareholders Equity $1.714B $1.740B $1.779B
YoY Change -3.64% -4.65% -3.38%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $32.91M -$17.00M $31.87M
YoY Change 3.26% -151.67% -32.48%
Depreciation, Depletion And Amortization $12.30M $13.30M $14.00M
YoY Change -12.14% -5.67% 6.87%
Cash From Operating Activities $35.30M $49.60M $51.40M
YoY Change -31.32% -33.51% 38.54%
INVESTING ACTIVITIES
Capital Expenditures -$12.60M -$13.00M -$9.500M
YoY Change 32.63% -21.69% -5.94%
Acquisitions
YoY Change
Other Investing Activities $2.500M -$4.600M $6.700M
YoY Change -62.69% -197.87% -133.5%
Cash From Investing Activities -$10.00M -$17.60M -$2.800M
YoY Change 257.14% 45.45% -90.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.20M -48.00M -40.90M
YoY Change -40.83% -28.57% 1473.08%
NET CHANGE
Cash From Operating Activities 35.30M 49.60M 51.40M
Cash From Investing Activities -10.00M -17.60M -2.800M
Cash From Financing Activities -24.20M -48.00M -40.90M
Net Change In Cash 1.100M -16.00M 7.700M
YoY Change -85.71% 240.43% 71.11%
FREE CASH FLOW
Cash From Operating Activities $35.30M $49.60M $51.40M
Capital Expenditures -$12.60M -$13.00M -$9.500M
Free Cash Flow $47.90M $62.60M $60.90M
YoY Change -21.35% -31.36% 29.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000310142
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Share Based Compensation
ShareBasedCompensation
-816000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6355000
CY2019Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
19185000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14493000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26073000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
23911000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14976000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7962000
CY2020Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
58534000
CY2019Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
91293000
CY2020Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
17491000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41706000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
254000
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
14901000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15053000
us-gaap Share Based Compensation
ShareBasedCompensation
4017000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1224000
sxt Disposal Group Not Discontinued Operation Gain Loss On Disposal And Other Charges
DisposalGroupNotDiscontinuedOperationGainLossOnDisposalAndOtherCharges
-5821000
sxt Disposal Group Not Discontinued Operation Gain Loss On Disposal And Other Charges
DisposalGroupNotDiscontinuedOperationGainLossOnDisposalAndOtherCharges
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9001000
us-gaap Net Income Loss
NetIncomeLoss
84303000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2303000
us-gaap Net Income Loss
NetIncomeLoss
99009000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36831000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17433000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5053000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9018000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19565000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7410000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1647000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3899000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-5294000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3936000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1920000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
142927000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127581000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34009000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1022000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2033000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
12228000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4955000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4280000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15804000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19760000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
33164000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
35126000
us-gaap Repayments Of Debt
RepaymentsOfDebt
101061000
us-gaap Repayments Of Debt
RepaymentsOfDebt
90966000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
49537000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
45688000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-415000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1027000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-117849000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-102555000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3527000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2745000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5747000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2521000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21153000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31901000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26900000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34422000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4726000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
859947000
us-gaap Net Income Loss
NetIncomeLoss
99009000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15755000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.08
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
45688000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-816000
sxt Nonvested Stock Issued Upon Vesting
NonvestedStockIssuedUponVesting
0
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1020000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23394000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.17
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
49537000
us-gaap Stockholders Equity Other
StockholdersEquityOther
1044000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
896673000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
897482000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
31871000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17767000
CY2019Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.36
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15235000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
339000
CY2019Q3 sxt Nonvested Stock Issued Upon Vesting
NonvestedStockIssuedUponVesting
0
CY2019Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
17000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
896673000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
881589000
us-gaap Net Income Loss
NetIncomeLoss
84303000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4017000
sxt Nonvested Stock Issued Upon Vesting
NonvestedStockIssuedUponVesting
0
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1074000
us-gaap Stockholders Equity Other
StockholdersEquityOther
414000
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.059
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.208
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.175
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
896785000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
860716000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
32910000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
18322000
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.39
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16519000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1355000
CY2020Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
896785000
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
7235000
sxt Number Of Product Lines Divested
NumberOfProductLinesDivested
3
us-gaap Restructuring Costs
RestructuringCosts
2641000
CY2020Q3 us-gaap Restructuring Costs
RestructuringCosts
2641000
us-gaap Restructuring Costs
RestructuringCosts
2641000
CY2020Q3 us-gaap Restructuring Costs
RestructuringCosts
2641000
sxt Number Of Portfolio Segments
NumberOfPortfolioSegments
1
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4890000
CY2020Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
148000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
453000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
207000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4792000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6913000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
504000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1080000
sxt Allowance For Doubtful Account Of Divestitures
AllowanceForDoubtfulAccountOfDivestitures
2174000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-224000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4792000
CY2020Q3 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
274500000
CY2019Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
313100000
CY2020Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
126500000
CY2019Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
109400000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
323566000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41155000
CY2020Q3 us-gaap Interest Expense
InterestExpense
3497000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37658000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
317650000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38788000
CY2019Q3 us-gaap Interest Expense
InterestExpense
4936000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
33852000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
997333000
us-gaap Operating Income Loss
OperatingIncomeLoss
117841000
us-gaap Interest Expense
InterestExpense
11412000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
106429000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1004349000
us-gaap Operating Income Loss
OperatingIncomeLoss
135576000
us-gaap Interest Expense
InterestExpense
15538000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
120038000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
323566000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
317650000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
997333000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1004349000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
323566000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
317650000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
997333000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1004349000
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.126
CY2020Q3 sxt Deferred Payroll Tax Payments
DeferredPayrollTaxPayments
3700000
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-16159000
CY2020Q3 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
18527000
CY2020Q3 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
205000
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-15414000
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
341000
CY2019Q3 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-17771000
CY2019Q3 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-4000
CY2020Q4 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2020-10-15
CY2020Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.39
CY2020Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2020-12-01

Files In Submission

Name View Source Status
0001140361-20-024396-index-headers.html Edgar Link pending
0001140361-20-024396-index.html Edgar Link pending
0001140361-20-024396.txt Edgar Link pending
0001140361-20-024396-xbrl.zip Edgar Link pending
brhc10013774_10q.htm Edgar Link pending
brhc10013774_10q_htm.xml Edgar Link completed
brhc10013774_31.htm Edgar Link pending
brhc10013774_32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sxt-20200930.xsd Edgar Link pending
sxt-20200930_cal.xml Edgar Link unprocessable
sxt-20200930_def.xml Edgar Link unprocessable
sxt-20200930_lab.xml Edgar Link unprocessable
sxt-20200930_pre.xml Edgar Link unprocessable